QpiAI Gen-1 25 qubit Quantum computer Indus, picture from QpiAI Bangalore centre with CEO Dr Nagendra Nagaraja (Left) and VP of Quantum hardware Dr Manjunath R V (Right).

Firefighters are urging residents to keep fire safety in mind to help avoid grass fires as the weather turns to spring. Brampton Fire and Emergency Services issued an alert on social media this ...

Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...

MANILA, Philippines – The head of a local group of pharmaceutical firms has expressed confidence that US President Donald Trump’s new tariff policy will have minimal impact on their sector ...

President Donald Trump announced plans for 'major' tariffs on pharmaceutical goods during a Republican dinner, triggering significant drops in global pharmaceutical stocks. Trump simultaneously ...

Tánaiste Simon Harris has said any future tariff negotiations between the EU and the US should include the pharmaceutical sector and other key industries. Speaking in Washington, following a ...

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

April 9 (UPI) --Pharmaceuticals produced in China could become costlier after President Donald Trump announced his intention to impose a "major tariff on pharmaceuticals." Trump said he would ...

“We are going to be announcing very shortly a major tariff on pharmaceuticals,” President Donald Trump says at a National Republican Congressional Committee Dinner. Trump suggests that pharmaceutical ...

President Donald Trump on Tuesday announced his next target for tariffs: the pharmaceutical industry. In remarks before the National Republican Congressional Committee, Trump said his administration ...

The drug modifies SMN2 gene splicing, improving motor neuron functionality. The plaintiffs, Roche, alleged that NATCO Pharma infringed their patent by initiating production of Risdiplam API (Active ...